BBI Grants

SpotSeq: A New Non-Invasive Test to Diagnose Genetic ‘Hotspots’ in Pediatric Vascular Malformations

December 01, 2022 | by BBI Communications

‘Advancing genetic diagnoses of children through the analysis of blood, rather than tissue’

Read More

BBI Provides $50,000 Grant to Evaluate Performance of Novel Diagnostic Techniques

June 20, 2022 | by BBI Communications

Funding will enable mentoring of UW Medicine fellow and compare optical genome mapping with proximity ligation sequencing

Read More

BBI’s Andrew Stergachis Named a Pew Biomedical Scholar to Study ‘Uncharted Regions of the Human Genome'

June 23, 2022 | by BBI Communications

Funding ‘provides resources and intellectual freedom to make a lasting impact on the future of epigenetics research’

Read More

BBI Funds Immunotherapy Research to Help Address Pancreatic and Kidney Cancers, a Project that ‘Exemplifies Precision Medicine’

April 12, 2022 | by BBI Communications

‘Killing is not the hard part for the immune system. The hard part is precisely killing the right thing.’

Read More

BBI Funds ‘Entirely Novel Approach’ to Studying Pediatric Leukemia

February 28, 2022 | by BBI Communications

‘Hope to potentially deliver more information and more confidence in assessing the potential – or even likelihood – of children relapsing’

Read More

Study of Electronic Health Records Demonstrates Value of Data in Referring Patients for Genetic Testing

June 11, 2021 | by BBI Communications

Members of the Brotman Baty Institute for Precision Medicine (BBI) are using electronic health records to identify women with a risk of having a genetic predisposition to breast cancer.

Read More

BBI ‘Catalytic Collaboration’ Grant Leads to ‘Extraordinary’ Progress in Research for Directing Treatment of Multiple Myeloma Patients

June 01, 2021 | by BBI COMMUNICATIONS

“Although recent advances have led to a surge in the number of therapies available to treat Multiple Myeloma, it remains a challenge to identify which treatment a patient is most likely to respond to.” Dr. David Coffey, Fred Hutchinson Cancer Research Center

Read More

BBI ‘Catalytic Collaboration Grant’ funded in 2019 Leads to Promising Genetic Diagnoses of Rare Diseases

May 03, 2021 | by BBI COMMUNICATIONS

“There is a need for better tools to identify a precise genetic diagnosis in individuals when conventional testing approaches have been exhausted.” – Dr. Evan Eichler, Professor of Genome Sciences, UW School of Medicine

Read More